R. Mass

4.5k citations
43 papers · 3.5k · 2 hit papers · h-index 21

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • HER2/EGFR in Cancer Research 12
    • Colorectal Cancer Treatments and Studies 12
    • Cancer Treatment and Pharmacology 10
    • Lung Cancer Research Studies 6
    • Lung Cancer Treatments and Mutations 5
    • Lung Cancer Diagnosis and Treatment 3

R. Mass

41 papers receiving 3.3k citations

R. Mass's Hit Papers

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer 2005 · 525 citations
5250+7+14Years since publication200400600

Peers

R. Mass
Comparison fields: 5 of 112
  • Oncology 2.1k
  • Hepatology 330
  • Pulmonary and Respiratory Medicine 895
  • Cancer Research 419
  • Radiology, Nuclear Medicine and Imaging 398
Replace Frank A. Scappaticci with:
Frank A. Scappaticci United States
Lowell L. Hart United States
Dana D. Hu‐Lowe United States
Emily Chan United States
Mohamed Hebbar France
Drew Rasco United States
Hisato Kawakami Japan
Carl Zuelke Germany
Heike Richly Germany
O. Kisker Germany
R. Mass relative to Frank A. Scappaticci United States Frank A. Scappaticci's profile →
Citations per field
00.5×3.0×
Frank A. Scappaticci · 1×
Citations per year

Countries citing papers authored by R. Mass

Since Specialization
Citations

This map shows the geographic impact of R. Mass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Mass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Mass more than expected).

Fields of papers citing papers by R. Mass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Mass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Mass. The network helps show where R. Mass may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Mass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Mass Line = papers co-authored together R. Mass links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
Hit paper breakdown →
2005710
2
Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer
Hit paper breakdown →
2005525
3 2005452
4 2005261
5 2006196
6 2008145
7 2005141
8 2001134
9 2004108
10 200399
11 200489
12
The role of HER-2 expression in predicting response to therapy in breast cancer.
200073
13 197952
14 200148
15 200246
16 197946
17 198945
18 200540
19 200440
20 201738

About R. Mass

R. Mass is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Hepatology and Molecular Biology, having authored 43 papers that have together received 3.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (10 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (2.1k citations), Hepatology (330 citations), Pulmonary and Respiratory Medicine (895 citations), Cancer Research (419 citations) and Radiology, Nuclear Medicine and Imaging (398 citations). R. Mass has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Fairooz F. Kabbinavar, Somnath Sarkar, Herbert I. Hurwitz, Julie Hambleton, Emily K. Bergsland, William Novotny, B. Nelson, J. Randolph Hecht, Michael McCleod and Joseph J. Schulz. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Hypertension, Breast Cancer Research and Treatment and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact